GL1X · GenesisL1 explorer

MolNFT v1 · #126411 · protein

Structure of cobinamide-bound btuf, the periplasmic vitamin B12 binding protein in E.COLI

5M29 · Vitamin B12-binding protein: “Structure of cobinamide-bound btuf, the periplasmic vitamin B12 binding protein in E.COLI”. X-ray diffraction, 2 ligands (CBY, CYN), 6 pockets (best druggability 0.75). MolNFT v1 #126411 on GenesisL1…

PDB
5M29
Type
protein
Length
458 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vitamin B12-binding protein
UniProt
P37028
Ligands
CBY, CYN
Pockets
6 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BVitamin B12-binding proteinprotein22941% helix, 17% strandP37028

Ligands and binding sites

  • CBY · Cob(ii)inamide · ligand · 2 copies · chains A, B
  • CYN · Cyanide ion · ion · 3 copies · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11800.750.9130GOL
210710.740.7778CBY, CYN
3960.370.7515empty
4650.310.7512empty
5610.300.7513empty

Interfaces

1 interface between chains.

  • A–B · 1140 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 5M29 · Structure of cobinamide-bound BtuF, the periplasmic vitamin B12 binding protein in E.coli · the same entry in another collection · chain A against A, TM-score 1.00
  • P37028 · AlphaFold monomer V2.0 prediction for vitamin B12-binding protein (P37028) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.